Protheragen, a specialized service provider focused on Active Pharmaceutical Ingredient (API) development and manufacturing, unveils its fully integrated suite of API services, combining API synthesis, scalable API contract manufacturing, and full-scope API testing to streamline drug R&D and commercialization for pharmaceutical enterprises worldwide.

Active Pharmaceutical Ingredients form the therapeutic core of all medicines, spanning oral capsules, injections, topical creams, and other finished dosage forms. As drug development pipelines grow more complex across small molecules, peptides, nucleic acids, and natural-derived therapeutics, pharma developers face mounting pressure to secure reliable, compliant partners capable of handling every stage from molecular design to commercial production and quality verification. Protheragen’s unified services address this industry pain point by eliminating fragmented third-party collaboration and delivering consistent regulatory-aligned outcomes across the entire API lifecycle.

Protheragen’s core offering lies in its custom API synthesis service, staffed by a cross-disciplinary team of organic chemistry specialists with deep expertise in designing cost-effective, scalable synthetic pathways for diverse API categories. The platform supports organic, inorganic, and biosynthesis workflows, covering small-molecule drugs, protein and peptide therapeutics, nucleic acid gene therapy APIs, natural extract-based compounds and synthetic biology-derived molecules. The standardized API synthesis workflow encompasses route design, raw material pretreatment, multi-step controlled reactions, multi-technique purification, and stage-by-stage quality control via HPLC, NMR, and mass spectrometry, ensuring high yield, purity, and minimal impurity generation for lab-scale to pre-commercial batches.

Complementing its lab-scale synthesis capacity, Protheragen delivers full-lifecycle API contract manufacturing as an end-to-end outsourced production solution. The service spans initial project consultation, customized process development, pilot scale-up, cGMP-compliant commercial manufacturing, and complete batch documentation delivery. Operating within state-of-the-art production facilities, Protheragen executes strict quality and regulatory adherence throughout all production phases, furnishing clients with transparent progress reporting, full reaction schematics, intermediate analytical records, and final quality certificates upon order completion. For each production campaign, residual intermediate samples are retained for one year to support future regulatory audits, offering pharmaceutical partners a stable, traceable API supply for clinical and commercial launch stages.

In addition to API synthesis and API contract manufacturing, Protheragen also offers API stability testing to validate safety, efficacy, and shelf-life compliance, forming a critical quality control pillar of Protheragen’s service ecosystem. Its API stability testing covers three standardized trial tiers: influence factor tests (high temperature, high humidity and strong light exposure for 10 days), 6-month accelerated stability trials, and 12-month long-term storage evaluations under industry-standard temperature and humidity conditions to define product expiry, degradation pathways, and optimal packaging specifications. Beyond stability assessment, its API testing suite extends to stress testing under extreme pH, heat and light, physical characteristic profiling (particle size, crystal polymorphism, solubility), impurity risk evaluation, and excipient compatibility studies to prevent formulation incompatibilities in final drug products.

Beyond these core offerings, Protheragen provides supplementary technical support including manufacturing process validation, technology transfer from laboratory to commercial scale, and customized analytical method development tailored to unique molecular structures. All operations align with global pharmaceutical regulatory standards, prioritizing impurity control, batch consistency, and data integrity for clients targeting global market authorization.